Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge
Arthur Allen | (TNS) KFF Health News When doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician …